Guardian Pharmacy Services, Inc.
GRDN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,228,409 | $1,046,193 | $908,909 | $792,072 |
| % Growth | 17.4% | 15.1% | 14.8% | – |
| Cost of Goods Sold | $984,038 | $837,883 | $723,043 | $630,807 |
| Gross Profit | $244,371 | $208,310 | $185,866 | $161,265 |
| % Margin | 19.9% | 19.9% | 20.4% | 20.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | -$3,381 | $13,029 |
| SG&A Expenses | $307,291 | $167,364 | $133,876 | $131,115 |
| Sales & Mktg Exp. | $0 | $0 | $137,257 | $118,086 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $307,291 | $167,364 | $133,876 | $131,115 |
| Operating Income | -$62,920 | $40,946 | $51,990 | $30,150 |
| % Margin | -5.1% | 3.9% | 5.7% | 3.8% |
| Other Income/Exp. Net | -$3,557 | -$3,226 | -$2,329 | -$1,824 |
| Pre-Tax Income | -$66,477 | $37,720 | $49,661 | $28,326 |
| Tax Expense | $4,556 | $0 | $0 | $0 |
| Net Income | -$87,287 | $23,902 | $35,421 | $16,314 |
| % Margin | -7.1% | 2.3% | 3.9% | 2.1% |
| EPS | -1.77 | 0.39 | 0.58 | 0.27 |
| % Growth | -553.8% | -32.8% | 114.8% | – |
| EPS Diluted | -1.77 | 0.39 | 0.58 | 0.27 |
| Weighted Avg Shares Out | 62,006 | 60,844 | 60,844 | 60,844 |
| Weighted Avg Shares Out Dil | 62,006 | 60,844 | 60,844 | 60,844 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,278 | $2,859 | $1,926 | $1,637 |
| Depreciation & Amortization | $19,772 | $18,234 | $16,563 | $16,530 |
| EBITDA | -$43,427 | $58,813 | $68,150 | $46,493 |
| % Margin | -3.5% | 5.6% | 7.5% | 5.9% |